Showing posts with label Biochips. Show all posts
Showing posts with label Biochips. Show all posts

Tuesday, 27 March 2018

Global Biochips Market Is Projected To Expand At A Steady 16.9% CAGR, With The Value Rising To US$22.2 Bn By 2023

Researchmoz added Most up-to-date research on "Biochips Market, (Type: DNA Chips, Protein Chips, Microfluidic Devices; Application: Drug Discovery & Development, Genomics, Proteomics and In Vitro Diagnostics) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023" to its huge collection of research reports.

This market research study analyzes the biochips market on global basis and provides estimates in terms of revenue (USD million) from 2014 to 2023. It describes the market dynamics affecting the industry and analyzes their impact through the forecast period. Moreover, it highlights the significant opportunities for market growth in the next eight years.

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=713929

Biochips are a collection of microarrays which are arranged on a solid substrate that enables numerous biochemical reactions such as decoding of genes in a few seconds. In addition, biochips are designed to function in biological environments and are capable of detecting and measuring a large number of biomarkers and perform complex biochemical reactions simultaneously in a very short span of time. There have been considerable advancements in the biotechnology industry on account of the increasing application of biochips. In addition, biochips are largely used for research in drug discovery and development, genomics, proteomics, and molecular diagnostics. Biochips help in analyzing organic molecules related to living organisms. Therefore, they help in detecting gene sequences, environmental pollutants, airborne toxins, and other biochemical constituents.

Increasing application of biochips in the medical sector for cancer treatment, drug research, and diagnostics is one of the major factors driving the growth of the global biochips market. In addition, factors such as availability of molecular information, automation of biochemical processes through the use of biochips and application of biochips for gene and protein identification are set to drive the global biochips market.

The use of biochips has brought about a transition in the field of drug discovery and research. Biochips have the ability to detect cancer before its symptoms develop in human bodies. In addition, it can easily detect virulent diseases such as smallpox, anthrax, and plague in a very short span of time. Moreover, biochips are increasingly finding application in veterinary diagnostics. Biochips comprise grids that may be dots or small wells. Each grid contains nucleic acid or antibodies and proteins which bind to a DNA sequence or a target antigen. The abundance of proteomics and genetics data coupled with the need for identifying gene sequences and proteins in human beings is driving the biochips market. Conventional gene and protein sequencing methods cannot provide qualitative output and are ineffective whereas biochips are extremely effective and produce accurate gene sequencing results in a very short span of time.

Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/biochips-market-global-industry-analysis-size-share-growth-trends-and-forecast-2015-2023-report.html/toc

Significant growth in the healthcare sector, rising demands for diagnostics and increasing medical expenditure coupled with economic reforms in major developing countries has been able to bolster the growth of this market. Asia Pacific and Rest of the World (RoW) are key markets for the future and are expected to provide huge opportunities to the global biochips manufacturers.

The market is segmented on the basis of geography into Europe, North America, Asia Pacific and Rest of the World (RoW). These segments have been estimated in terms of revenue (USD million). In addition, the report has been segmented based on types, which includes DNA chips, protein chips and microfluidic devices. In addition, the report is also segmented by application that includes drug discovery & development, genomics, proteomics and in vitro diagnostics.

For better understanding of the biochips market, the study comprises market attractiveness analysis, where the types of biochips are benchmarked based on their market scope, growth rate and market attractiveness.

The report also provides company market share analysis of the various industry participants. Key players have been profiled and their company overview, financial overview, business strategies and recent developments have been covered in the report. Major market participants profiled in this report include Affymetrix Inc., Illumina Inc., GE Healthcare Ltd., Agilent Technologies Inc., Fluidigm Corporation and Cepheid Inc. among others.

The biochips market has been segmented as:

Global Biochips Market: By Type

- DNA Chips
- Protein Chips
- Microfluidic Devices

Global Biochips Market: By Application

- Drug Discovery & Development
- Genomics
- Proteomics
- In Vitro Diagnostics

Make an Enquiry of this report @ https://www.researchmoz.us/enquiry.php?type=E&repid=713929

Global Biochips Market: By Geography

- North America
- U.S.
- Canada
- Mexico
- Europe
- U.K.
- Italy
- France
- Germany
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Rest of the World (RoW)
- Latin America
- U.A.E.
- South Africa
- Others

The report provides a cross-sectional analysis of by type and of by application segment with respect to the above mentioned regions

Friday, 14 July 2017

Global Biochips Market 2016-2020 Key Vendors – Affymetrix, Agilent Technologies, Cellix, Illumina, PerkinElmer

Researchmoz added Most up-to-date research on "Global Biochips Market 2016-2020" to its huge collection of research reports.

Bio-microsystems are a group of integrated and miniaturized devices that are used in biochemical reactions and biological monitoring, diagnostics, research and development, and therapy. Some of the advantages of using bio-microsystems are integrated intelligence, parallelism, low cost, redundancy, and speed. A biochip is an example of a bio-microsystem; it is a collection of microarrays organized on a solid substrate, allowing thousands of complex biochemical reactions, including decoding genes, in less time.

Browse Detail Report With TOC @ http://www.researchmoz.us/global-biochips-market-2016-2020-report.html

Technavios analysts forecast the global biochips market to grow at a CAGR of 17.02% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global biochips market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of biochips for applications, including drug discovery and development, diagnostics and treatment, research and consumables, forensic medicines, and others.
The market is divided into the following segments based on geography:
APAC
Europe
North America
ROW

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=715951

Global Biochips Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
Affymetrix
Agilent Technologies
Cellix
Illumina
PerkinElmer

Other prominent vendors
Biochain Institute
Bio-Rad Laboratories
Cepheid
EMD Millipore
Fluidigm
SuperBioChips Laboratories
US Biomax

Market driver
Adoption of biochip technology in drug discovery
For a full, detailed list, view our report

Market challenge
Standardization, reliability, accuracy, and precision issues
For a full, detailed list, view our report

Market trend
Emergence of microarray technology
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=715951

Sunday, 7 May 2017

At A CAGR Of 17.02% Global Biochips Market To Grow During The Period 2016-2020

Researchmoz added Most up-to-date research on "Global Biochips Market 2016-2020" to its huge collection of research reports.

Bio-microsystems are a group of integrated and miniaturized devices that are used in biochemical reactions and biological monitoring, diagnostics, research and development, and therapy. Some of the advantages of using bio-microsystems are integrated intelligence, parallelism, low cost, redundancy, and speed. A biochip is an example of a bio-microsystem; it is a collection of microarrays organized on a solid substrate, allowing thousands of complex biochemical reactions, including decoding genes, in less time.

Technavios analysts forecast the global biochips market to grow at a CAGR of 17.02% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global biochips market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of biochips for applications, including drug discovery and development, diagnostics and treatment, research and consumables, forensic medicines, and others.
The market is divided into the following segments based on geography:
APAC
Europe
North America
ROW

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=715951

Technavio's report, Global Biochips Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
Affymetrix
Agilent Technologies
Cellix
Illumina
PerkinElmer

Other prominent vendors
Biochain Institute
Bio-Rad Laboratories
Cepheid
EMD Millipore
Fluidigm
SuperBioChips Laboratories
US Biomax

Market driver
Adoption of biochip technology in drug discovery
For a full, detailed list, view our report

Market challenge
Standardization, reliability, accuracy, and precision issues
For a full, detailed list, view our report

Market trend
Emergence of microarray technology
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=715951

Wednesday, 5 April 2017

Global Biochips Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

Researchmoz added Most up-to-date research on "Biochips Market, (Type: DNA Chips, Protein Chips, Microfluidic Devices; Application: Drug Discovery & Development, Genomics, Proteomics and In Vitro Diagnostics) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023" to its huge collection of research reports.

This market research study analyzes the biochips market on global basis and provides estimates in terms of revenue (USD million) from 2014 to 2023. It describes the market dynamics affecting the industry and analyzes their impact through the forecast period. Moreover, it highlights the significant opportunities for market growth in the next eight years.

Biochips are a collection of microarrays which are arranged on a solid substrate that enables numerous biochemical reactions such as decoding of genes in a few seconds. In addition, biochips are designed to function in biological environments and are capable of detecting and measuring a large number of biomarkers and perform complex biochemical reactions simultaneously in a very short span of time. There have been considerable advancements in the biotechnology industry on account of the increasing application of biochips. In addition, biochips are largely used for research in drug discovery and development, genomics, proteomics, and molecular diagnostics. Biochips help in analyzing organic molecules related to living organisms. Therefore, they help in detecting gene sequences, environmental pollutants, airborne toxins, and other biochemical constituents.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=713929

Increasing application of biochips in the medical sector for cancer treatment, drug research, and diagnostics is one of the major factors driving the growth of the global biochips market. In addition, factors such as availability of molecular information, automation of biochemical processes through the use of biochips and application of biochips for gene and protein identification are set to drive the global biochips market. 

The use of biochips has brought about a transition in the field of drug discovery and research. Biochips have the ability to detect cancer before its symptoms develop in human bodies. In addition, it can easily detect virulent diseases such as smallpox, anthrax, and plague in a very short span of time. Moreover, biochips are increasingly finding application in veterinary diagnostics. Biochips comprise grids that may be dots or small wells. Each grid contains nucleic acid or antibodies and proteins which bind to a DNA sequence or a target antigen. The abundance of proteomics and genetics data coupled with the need for identifying gene sequences and proteins in human beings is driving the biochips market. Conventional gene and protein sequencing methods cannot provide qualitative output and are ineffective whereas biochips are extremely effective and produce accurate gene sequencing results in a very short span of time.

Significant growth in the healthcare sector, rising demands for diagnostics and increasing medical expenditure coupled with economic reforms in major developing countries has been able to bolster the growth of this market. Asia Pacific and Rest of the World (RoW) are key markets for the future and are expected to provide huge opportunities to the global biochips manufacturers.

The market is segmented on the basis of geography into Europe, North America, Asia Pacific and Rest of the World (RoW). These segments have been estimated in terms of revenue (USD million). In addition, the report has been segmented based on types, which includes DNA chips, protein chips and microfluidic devices. In addition, the report is also segmented by application that includes drug discovery & development, genomics, proteomics and in vitro diagnostics.

For better understanding of the biochips market, the study comprises market attractiveness analysis, where the types of biochips are benchmarked based on their market scope, growth rate and market attractiveness.

The report also provides company market share analysis of the various industry participants. Key players have been profiled and their company overview, financial overview, business strategies and recent developments have been covered in the report. Major market participants profiled in this report include Affymetrix Inc., Illumina Inc., GE Healthcare Ltd., Agilent Technologies Inc., Fluidigm Corporation and Cepheid Inc. among others.

The biochips market has been segmented as:

Global Biochips Market: By Type

- DNA Chips
- Protein Chips
- Microfluidic Devices

Global Biochips Market: By Application

- Drug Discovery & Development
- Genomics
- Proteomics
- In Vitro Diagnostics

Global Biochips Market: By Geography

- North America
- U.S.
- Canada
- Mexico
- Europe
- U.K.
- Italy
- France
- Germany
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Rest of the World (RoW)
- Latin America
- U.A.E.
- South Africa
- Others

The report provides a cross-sectional analysis of by type and of by application segment with respect to the above mentioned regions

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=713929

Monday, 23 January 2017

Biochips Global Market Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 | Researchmoz.us

Researchmoz added Most up-to-date research on "Biochips Market, (Type: DNA Chips, Protein Chips, Microfluidic Devices; Application: Drug Discovery & Development, Genomics, Proteomics and In Vitro Diagnostics) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023" to its huge collection of research reports.

This market research study analyzes the biochips market on global basis and provides estimates in terms of revenue (USD million) from 2014 to 2023. It describes the market dynamics affecting the industry and analyzes their impact through the forecast period. Moreover, it highlights the significant opportunities for market growth in the next eight years.

Biochips are a collection of microarrays which are arranged on a solid substrate that enables numerous biochemical reactions such as decoding of genes in a few seconds. In addition, biochips are designed to function in biological environments and are capable of detecting and measuring a large number of biomarkers and perform complex biochemical reactions simultaneously in a very short span of time. There have been considerable advancements in the biotechnology industry on account of the increasing application of biochips. In addition, biochips are largely used for research in drug discovery and development, genomics, proteomics, and molecular diagnostics. Biochips help in analyzing organic molecules related to living organisms. Therefore, they help in detecting gene sequences, environmental pollutants, airborne toxins, and other biochemical constituents.

Increasing application of biochips in the medical sector for cancer treatment, drug research, and diagnostics is one of the major factors driving the growth of the global biochips market. In addition, factors such as availability of molecular information, automation of biochemical processes through the use of biochips and application of biochips for gene and protein identification are set to drive the global biochips market. 

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=713929

The use of biochips has brought about a transition in the field of drug discovery and research. Biochips have the ability to detect cancer before its symptoms develop in human bodies. In addition, it can easily detect virulent diseases such as smallpox, anthrax, and plague in a very short span of time. Moreover, biochips are increasingly finding application in veterinary diagnostics. Biochips comprise grids that may be dots or small wells. Each grid contains nucleic acid or antibodies and proteins which bind to a DNA sequence or a target antigen. The abundance of proteomics and genetics data coupled with the need for identifying gene sequences and proteins in human beings is driving the biochips market. Conventional gene and protein sequencing methods cannot provide qualitative output and are ineffective whereas biochips are extremely effective and produce accurate gene sequencing results in a very short span of time.

Significant growth in the healthcare sector, rising demands for diagnostics and increasing medical expenditure coupled with economic reforms in major developing countries has been able to bolster the growth of this market. Asia Pacific and Rest of the World (RoW) are key markets for the future and are expected to provide huge opportunities to the global biochips manufacturers.

The market is segmented on the basis of geography into Europe, North America, Asia Pacific and Rest of the World (RoW). These segments have been estimated in terms of revenue (USD million). In addition, the report has been segmented based on types, which includes DNA chips, protein chips and microfluidic devices. In addition, the report is also segmented by application that includes drug discovery & development, genomics, proteomics and in vitro diagnostics.

For better understanding of the biochips market, the study comprises market attractiveness analysis, where the types of biochips are benchmarked based on their market scope, growth rate and market attractiveness.

The report also provides company market share analysis of the various industry participants. Key players have been profiled and their company overview, financial overview, business strategies and recent developments have been covered in the report. Major market participants profiled in this report include Affymetrix Inc., Illumina Inc., GE Healthcare Ltd., Agilent Technologies Inc., Fluidigm Corporation and Cepheid Inc. among others.

The biochips market has been segmented as:

Global Biochips Market: By Type

- DNA Chips
- Protein Chips
- Microfluidic Devices

Global Biochips Market: By Application

- Drug Discovery & Development
- Genomics
- Proteomics
- In Vitro Diagnostics

Global Biochips Market: By Geography

- North America
- U.S.
- Canada
- Mexico
- Europe
- U.K.
- Italy
- France
- Germany
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Rest of the World (RoW)
- Latin America
- U.A.E.
- South Africa
- Others

The report provides a cross-sectional analysis of by type and of by application segment with respect to the above mentioned regions

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=713929

Blood Thawing System Market Insights Shared in Detailed Report

Blood Thawing System Market: Introduction According to the report, the global  blood thawing system market  was valued at ~US$ 174 Mn in 2...